SCHEMBL6995696

SCHEMBL6995696

COc1ccc(C2=C(c3ccc(SC)cc3)OC(C)(C)C2=O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.50
CYP1A1 P04798 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP1B1 Q16678 1/20 0.42
PTGS2 P35354 5/20 0.40
ME2 P23368 1/20 0.39
ME1 P48163 1/20 0.39
ME3 Q16798 1/20 0.39
EDNRA P25101 3/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 2/20 0.38
KDM4E B2RXH2 1/20 0.38
PTGS1 P23219 1/20 0.38
HTT P42858 1/20 0.36
STK10 O94804 1/20 0.36
SLK Q9H2G2 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
EDNRB P24530 1/20 0.36
GAA P10253 1/20 0.35
EGFR P00533 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6994402 0.85 PTGS2 (0.58) GSK3BPTGS2ALDH1A1HPGDKDM4E
SCHEMBL286649 0.83 ESR2 (0.50) ME2ME1ME3EDNRAALDH1A1
SCHEMBL1419877 0.83 ESR2 (0.50) ME2ME1ME3EDNRAALDH1A1
SCHEMBL6996876 0.80 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL6997348 0.80 GSK3B (0.53) GSK3BPTGS2ALDH1A1KDM4EPTGS1
SCHEMBL7002310 0.80 PTGS2 (0.59) PTGS2PTGS1
SCHEMBL7897258 0.79 PTGS2 (0.41) CYP1A2PTGS2HPGD
SCHEMBL12188829 0.79 PTGS2 (0.41) CYP1A2PTGS2HPGD
SCHEMBL6999809 0.79 PTGS2 (0.46) PTGS2KDM4EPTGS1TDP1
SCHEMBL6997397 0.78 PTGS2 (0.38) PTGS2ALDH1A1HPGDKDM4EPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109799-B1 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS PACIFIC CORP (KR) 2003-12-17 EP claimed
US-6492416-B1 TREATING INFLAMMATION AND ASSOCIATED DISORDERS PACIFIC CORPORATION (KR) 2002-12-10 US claimed
EP-1109799-A1 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS PACIFIC CORPORATION (KR) 2001-06-27 EP claimed
WO-2000061571-A1 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS PACIFIC CORPORATION (KR) 2000-10-19 WO claimed
EP-1109799-B1 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS PACIFIC CORP (KR) 2003-12-17 EP disclosed
US-6492416-B1 TREATING INFLAMMATION AND ASSOCIATED DISORDERS PACIFIC CORPORATION (KR) 2002-12-10 US disclosed
EP-1109799-A1 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS PACIFIC CORPORATION (KR) 2001-06-27 EP disclosed
WO-2000061571-A1 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS PACIFIC CORPORATION (KR) 2000-10-19 WO disclosed